The Role of Antifungal Medications in Treating Systemic Infections

How antifungals work to fight fungal infections that spread through the body, and why choosing the right drug matters.

By Garret Merkley · Explainer · Jun 11, 2026

Branched from Understanding Histoplasmosis: Symptoms, Diagnosis, and Treatment

Quick take

Systemic fungal infections spread through the bloodstream and organs, requiring antifungals that reach deep into tissue—not just surface treatments.
Different antifungal classes work differently: azoles disrupt cell membranes, polyenes poke holes in them, and echinocandins weaken cell walls.
Severity of infection, fungal species, organ involvement, and patient kidney/liver function all determine which antifungal gets prescribed and for how long.

A systemic fungal infection means the fungus has entered the bloodstream and spread to multiple organs—lungs, brain, heart, kidneys—rather than staying on skin or mucous membranes. Antifungal medications are designed to kill or stop the growth of these fungi throughout the body. Unlike topical creams for athlete's foot, systemic antifungals must be potent enough to reach infected tissues deep inside the body, cross protective barriers like the blood-brain barrier, and work fast enough to prevent organ damage.

How Antifungals Attack Fungal Cells

Antifungal drugs work by targeting structures or processes unique to fungal cells, leaving human cells relatively unharmed. The main classes use different strategies. Azole antifungals (fluconazole, itraconazole, voriconazole) block an enzyme the fungus needs to build its cell membrane, causing it to leak and die. Polyene antifungals (amphotericin B) bind directly to the fungal cell membrane and poke holes in it, destroying the cell. Echinocandins (caspofungin, micafungin) weaken the fungal cell wall by blocking the synthesis of a critical structural component called beta-glucan. Each approach is effective against different fungal species, which is why doctors choose based on what organism is causing the infection.

Choosing the Right Antifungal

The choice of antifungal depends on several factors. First, which fungus is it? Histoplasma, Candida, Aspergillus, and Cryptococcus each respond differently to different drugs. Second, where is the infection? Fungal meningitis (brain infection) requires an antifungal that crosses the blood-brain barrier well—fluconazole and voriconazole do this better than others. Third, how severe is it? Life-threatening infections often start with amphotericin B (highly potent but more toxic) and may switch to a gentler azole once the patient stabilizes. Fourth, what is the patient's kidney and liver function? These organs metabolize most antifungals, so damage to them means lower doses or different drugs.

Treatment duration varies widely. A mild lung infection might need 6–12 weeks of fluconazole. Severe disseminated infection or fungal meningitis can require months of therapy, sometimes a year or longer. Doctors monitor blood levels of the drug (when available) and watch for signs the infection is clearing on imaging and in blood cultures.

Why Antifungals Matter for Systemic Infection

Systemic fungal infections are rare but dangerous. People with weakened immune systems—those with HIV/AIDS, on immunosuppressant drugs after transplant, or undergoing chemotherapy—are at highest risk. Without effective antifungals, these infections can cause organ failure, sepsis, or death. Even in immunocompetent people, inhalation of certain fungal spores (like Histoplasma from soil) can trigger serious lung and disseminated disease. Antifungals are often the only treatment that works; surgery or immune support alone won't clear a bloodstream infection. The challenge is that some antifungals have significant side effects—amphotericin B can damage kidneys—so doctors balance efficacy against tolerability, especially for long-term treatment.

Common Antifungal Classes and Their Uses

Azoles (fluconazole, itraconazole, voriconazole): First-line for many systemic infections; good oral absorption; relatively well tolerated.
Polyenes (amphotericin B, liposomal formulation): Reserved for severe or resistant infections; excellent tissue penetration; higher risk of kidney toxicity.
Echinocandins (caspofungin, micafungin, anidulafungin): Often used for Candida bloodstream infections; good safety profile; given intravenously.
Allylamines (terbinafine): Less commonly used systemically; mainly for dermatophyte infections.

Resistance and Treatment Failure

Over time and with repeated antifungal exposure, some fungi develop resistance—they alter their cell membranes, pump out the drug, or change the target enzyme. This is less common than bacterial antibiotic resistance but is rising, especially with Candida auris and some Aspergillus species. When a fungus stops responding to one antifungal, doctors may switch to a different class or combine two drugs. This is why accurate identification of the fungus and antifungal susceptibility testing (done in the lab) are critical—they guide the best choice from the start and help catch resistance early.

Can you take antifungal pills instead of IV for a serious systemic infection?

Sometimes, but not always. Severe or rapidly progressive infections usually start with IV antifungals to get high drug levels into the bloodstream fast. Once stable, many patients can switch to oral pills (like fluconazole) to complete treatment at home. The choice depends on the fungus, organ involvement, and how quickly the patient improves.

How long does it take antifungals to work?

Some improvement in symptoms can appear within days to a week, but fungal infections are slow to clear. Blood cultures may become negative within 1–2 weeks, but imaging of the lungs or organs may take weeks to months to normalize. Full recovery and stopping the drug can take months.

What are the main side effects of antifungal medications?

Azoles can cause nausea, headache, and liver enzyme changes. Amphotericin B commonly causes fever, chills, and kidney injury (monitored closely). Echinocandins are generally well tolerated. All require regular blood tests to watch for organ damage, especially during long-term use.

Why can't antibiotics treat fungal infections?

Antibiotics target bacterial cell walls and membranes, which are structurally different from fungal ones. Fungi are eukaryotes (like human cells), while bacteria are prokaryotes. Antifungals are designed to exploit fungal-specific features without harming human cells.

Can someone get a fungal infection again after treatment?

Yes, especially if the immune system is still weak. People with untreated HIV or ongoing immunosuppression may relapse or reinfect. This is why immune reconstitution (raising CD4 counts with antiretroviral therapy, for example) is as important as the antifungal itself in preventing recurrence.

Sources

Antifungal stewardship and resistance: an urgent call to action. Infectious Diseases Society of America clinical practice guidelines emphasize azole, polyene, and echinocandin mechanisms and resistance patterns.
Amphotericin B formulations and nephrotoxicity: liposomal formulations reduce kidney injury compared to conventional amphotericin B deoxycholate.
Fluconazole CNS penetration: achieves therapeutic levels in cerebrospinal fluid, making it suitable for fungal meningitis (typically 400–800 mg daily).